Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Join | Sign in
Home>Resources>Webcasts

  Webcasts

Scientific News
New Molecule Could Slow The Progression Of Parkinson’s
University of Bath researchers have designed a molecule that, if developed into a drug, could slow the progression of Parkinson's Disease.
Study Could Pave the Way for Painkillers with Fewer Side Effects
Research at SLAC explores promising alternative to morphine.
Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
A novel microdevice capable of detecting 42 unique immune effector proteins has been developed.
Possible Neuron Killing Mechanism Behind Alzheimer’s and Parkinson’s Diseases Discovered
$1.4 million grant will enable team to follow up with search for drug candidates.
MAGE Genes Provide Insight into Optimizing Chemotherapy
UT Southwestern Medical Center scientists have identified a new biomarker that could help identify patients who are more likely to respond to certain chemotherapies.
New Screening Tool Could Speed Development Of Ovarian Cancer Drugs
Researchers have built a 3D cell culture system which can help identify small molecules that could be used to treat ovarian cancer.
New Biomarkers To Spot Pancreatic Cancer Early
A combination of two biomarkers can identify pre-clinical pancreatic cancer.
Artificially-intelligent Robot Scientist ‘Eve’ Could Boost Search for New Drugs
Eve, an artificially-intelligent ‘robot scientist’ could make drug discovery faster and much cheaper, say researchers writing in the Royal Society journal Interface.
New Metabolic Biomarkers Predict Future Cardiovascular Diseases
Scientists of the Helmholtz Zentrum München contributed to the analysis of the biomarkers.
New Cancer-Fighting Strategy Would Harden Cells to Prevent Metastasis
Potential drug for pancreatic cancer now being tested in animals.

The Potential of Selected Adenylyl Cyclases Isoforms as Potential Drug Targets
Klaus Scholich, Institute of Clinical Pharmacology, Goethe University Frankfurt, speaking at Screening Europe 2010

A Cell Based Screening Platform for the Identification of Small Molecule-Protein Interactions
Mandana Rezwan, Head R&D, Dualsystems Biotech AG, speaking at Screening Europe 2010

Voltage-Gated Sodium Channel Activators with Differing Efficacies Stimulate Neurite Outgrowth in Cerebrocortical Neurons
Thomas Murray, Professor and Chair, Creighton University School of Medicine, speaking at Screening Europe 2010

What Are The Right Assays to Select? Studies With Receptors for Free Fatty Acids’
Graeme Milligan, Professor, University of Glasgow, speaking at Screening Europe 2010

Indirect Inhibition Assays and Droplet-Based Microfluidics
Christoph Merten, Junior Group Leader, University of Strasbourg, speaking at Screening Europe 2010

Thermo-TRP Ion Channels as Drug Targets
Peter McNaughton, Professor, University of Cambridge, speaking at Screening Europe 2010

Physiologically Based Pharmacokinetic/Pharmacodynamic Modelling for Lead Optimisation of CNS-Active Therapeutics
Simon Thomas, Cyprotex, speaking at Screening Europe 2010

Predicting Hepatotoxicity with CellCiphr HCS technology: Rat and Human Hepatotoxicity Predicton: Validation and Case Studies
Katya Tsaioun, CSO, Cyprotex speaking at ADMET Europe 2011

Diversity Screening for Alternate Modes of Inhibition of Protein Kinase Targets
Julio Martin, Group Manager, GlaxoSmithKline, speaking at Screening Europe 2010

<< 8 9 10 11 12 13 14 >>
Showing Results 101 - 110 of 260
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters